Suppr超能文献

阴道用米索前列醇治疗胎膜早破

Vaginal misoprostol in managing premature rupture of membranes.

作者信息

Ayad I A A

机构信息

Prince Rashid Ibn Al-Hassan Hospital, Ramtha, Jordan.

出版信息

East Mediterr Health J. 2002 Jul-Sep;8(4-5):515-20.

Abstract

We compared the efficacy of misoprostol with that of prostaglandin E2 in cervical ripening and labour induction. Thus 238 women with rupture of membranes beyond 36 weeks gestation without labour were randomized to receive 50 microg misoprostol vaginal gel or 5 mg of prostaglandin E2 gel. Bishop score was evaluated before drug application and 6 hours later. Clinical data and perinatal outcome were recorded. Mean time from induction to delivery and the need for oxytocin were significantly less in the misoprostol group. There were no significant differences in spontaneous labour rate, type of delivery and perinatal outcome. It is concluded that intravaginal misoprostol is safe and more effective than prostaglandin E2 for preinduction cervical ripening in premature rupture of membranes beyond 36 weeks gestation.

摘要

我们比较了米索前列醇与前列腺素E2在宫颈成熟和引产方面的疗效。因此,将238例妊娠36周以上胎膜早破且未临产的妇女随机分为两组,分别接受50微克米索前列醇阴道凝胶或5毫克前列腺素E2凝胶治疗。用药前及用药6小时后评估Bishop评分。记录临床数据和围产期结局。米索前列醇组从引产到分娩的平均时间和催产素的使用需求明显更少。自然分娩率、分娩方式和围产期结局方面无显著差异。结论是,对于妊娠36周以上胎膜早破的引产术前宫颈成熟,阴道内使用米索前列醇比前列腺素E2更安全、更有效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验